Neurotransmitters: emerging targets in cancer - Jiang, Shu-Heng; Hu, Li-Peng; Wang, Xu; Li, Jun; Zhang, Zhi-Gang (Oncogene, 2020)
Keywords: 13/21; 38/39; 42/47; 45/41; 631/67/327; 631/80/86/2363; Angiogenesis; Animals; Antineoplastic Agents - therapeutic use; Antitumor activity; Apoptosis; B cells; Cancer; Carcinogenesis - drug effects; Carcinogenesis - pathology; Cell Biology; Cell proliferation; Development and progression; Disease Models, Animal; Endothelial cells; Human Genetics; Humans; Inflammation; Inflammation - drug therapy; Inflammation - immunology; Inflammation - pathology; Internal Medicine; Medicine; Medicine & Public Health; Mice; Neoplasms - blood supply; Neoplasms - drug therapy; Neoplasms - immunology; Neoplasms - pathology; Neovascularization, Pathologic - drug therapy; Neovascularization, Pathologic - immunology; Neovascularization, Pathologic - pathology; Neurophysiology; Neurotransmitter Agents - antagonists & inhibitors; Neurotransmitter Agents - metabolism; Neurotransmitters; Oncology; Physiological aspects; Receptors, Neurotransmitter - antagonists & inhibitors; Receptors, Neurotransmitter - metabolism; Review Article; Signal transduction; Signal Transduction - drug effects; Tumor Microenvironment - drug effects; Tumor Microenvironment - immunology; Tumorigenesis